Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Varenicline Tablets, 0.5 mg and 1 mg, the company announced through an exchange filing. The product will be launched shortly.
Varenicline tablets are indicated to treat smoking addiction. The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India.
Varenicline Tablets, 0.5 mg and 1 mg had annual sales of USD 501 mn in the United States.
The group now has 374 approvals and has so far filed over 442 ANDAs since the commencement of the filing process in FY 2003-04.
Mumbai: Borivali School Authority Makes Obscene Comment When Parent Asks About Fee Hike, ‘Wife Ko Humare Paas Bhej Dena…’ | Watch
Kyunki Saas Bhi Kabhi Bahu Thi 2 Written Update, December 22: Pari's Birthday Turns Into A Family Feud
'We Love Shilpa Shinde As Angoori': Bhabiji Ghar Par Hain Fans Celebrate Actress's Grand Comeback After Nearly 10 Years
Anupamaa Written Update, December 22: Ishani Steals Bharti's Jewelry Before The Wedding
